Drug Shortage Report for BOOSTRIX-POLIO
| Report ID | 196056 |
| Drug Identification Number | 02312557 |
| Brand name | BOOSTRIX-POLIO |
| Common or Proper name | Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INACTIVATED POLIOVIRUS TYPE III INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE I PERTACTIN ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTUSSIS TOXOID ADSORBED TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED |
| Strength(s) | 32D 8D 40D 2.5MCG 8MCG 8MCG 5.0LF 2.5LF |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10's |
| ATC code | J07CA |
| ATC description | BACTERIAL AND VIRAL VACCINES, COMBINED |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-20 |
| Estimated end date | 2023-10-18 |
| Actual end date | 2023-10-02 |
| Shortage status | Resolved |
| Updated date | 2023-10-04 |
| Company comments | Supply unavailable |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-10-04 | French | Compare |
| v5 | 2023-10-04 | English | Compare |
| v4 | 2023-06-21 | French | Compare |
| v3 | 2023-06-21 | English | Compare |
| v2 | 2023-06-21 | French | Compare |
| v1 | 2023-06-21 | English | Compare |
Showing 1 to 6 of 6